Expression of OTUB1 in hepatocellular carcinoma and its effects on HCC cell migration and invasion
Tóm tắt
Từ khóa
Tài liệu tham khảo
2015, Preclinical model in HCC: the SGK1 kinase inhibitor SI113 blocks tumor progression in vitro and in vivo and synergizes with radiotherapy, Oncotarget, 6, 37511, 10.18632/oncotarget.5527
2010, Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008, Int J Cancer, 127, 2893, 10.1002/ijc.25516
2007, Hepatocellular carcinoma: trends of incidence and survival in Europe and the United States at the end of the 20th century, Am J Gastroenterol, 102, 1661, 10.1111/j.1572-0241.2007.01337.x
2004, Hepatocellular carcinoma: recent trends in the United States, Gastroenterology, 127, S27, 10.1053/j.gastro.2004.09.013
2008, Survival analysis of patients with transplantable recurrent hepatocellular carcinoma: implications for salvage liver transplant, Arch Surg, 143, 68, 10.1001/archsurg.2007.15
2007, PIVKA-II is a useful tumor marker for recurrent hepatocellular carcinoma after surgical resection, Oncology, 72, 52, 10.1159/000111707
2015, Current trends and recent advances in diagnosis, therapy, and prevention of hepatocellular carcinoma, Asian Pac J Cancer Prev, 16, 3595, 10.7314/APJCP.2015.16.9.3595
2003, Otubains: a new family of cysteine proteases in the ubiquitin pathway, EMBO Rep, 4, 517, 10.1038/sj.embor.embor824
2009, Defining the human deubiquitinating enzyme interaction landscape, Cell, 138, 389, 10.1016/j.cell.2009.04.042
2005, A genomic and functional inventory of deubiquitinating enzymes, Cell, 123, 773, 10.1016/j.cell.2005.11.007
2000, A novel superfamily of predicted cysteine proteases from eukaryotes, viruses and Chlamydia pneumoniae, Trends Biochem Sci, 25, 50, 10.1016/S0968-0004(99)01530-3
2016, OTUB1 inhibits the ubiquitination and degradation of FOXM1 in breast cancer and epirubicin resistance, Oncogene, 35, 1433, 10.1038/onc.2015.208
2004, Two isoforms of otubain 1 regulate T cell anergy via GRAIL, Nat Immunol, 5, 45, 10.1038/ni1017
2013, OTUB1 enhances TGFβ signalling by inhibiting the ubiquitylation and degradation of active SMAD2/3, Nat Commun, 4, 2519, 10.1038/ncomms3519
2013, OTUB1 modulates c-IAP1 stability to regulate signalling pathways, EMBO J, 32, 1103, 10.1038/emboj.2013.62
2015, OTUB1 de-ubiquitinating enzyme promotes prostate cancer cell invasion in vitro and tumorigenesis in vivo, Mol Cancer, 14, 8, 10.1186/s12943-014-0280-2
2016, OTUB1 triggers lung cancer development by inhibiting RAS monoubiquitination, EMBO Mol Med, 8, 288, 10.15252/emmm.201505972
2014, OTUB1 promotes metastasis and serves as a marker of poor prognosis in colorectal cancer, Mol Cancer, 13, 258, 10.1186/1476-4598-13-258
2016, OTUB1-catalyzed deubiquitination of FOXM1 facilitates tumor progression and predicts a poor prognosis in ovarian cancer, Oncotarget, 7, 36681, 10.18632/oncotarget.9160
1993, Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma, Gastroenterology, 105, 488, 10.1016/0016-5085(93)90724-Q
1996, Recurrence of hepatocellular carcinoma after surgery, Br J Surg, 83, 1219, 10.1002/bjs.1800830913
2006, A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells, Nat Med, 12, 410, 10.1038/nm1377
2011, Risk factors, prognosis, and management of early and late intrahepatic recurrence after resection of primary clear cell carcinoma of the liver, Ann Surg Oncol, 18, 1955, 10.1245/s10434-010-1540-z
2004, High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations, Int J Cancer, 112, 44, 10.1002/ijc.20279
2001, Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status, J Hepatol, 34, 570, 10.1016/S0168-8278(00)00053-2
2011, Clinical utility of highly sensitive Lens culinaris agglutinin-reactive alpha-fetoprotein in hepatocellular carcinoma patients with alpha-fetoprotein <20 ng/mL, Cancer Sci, 102, 1025, 10.1111/j.1349-7006.2011.01875.x
2016, OTUB1 inhibits the ubiquitination and degradation of FOXM1 in breast cancer and epirubicin resistance, Oncogene, 35, 1433, 10.1038/onc.2015.208
2016, OTUB1 promotes tumor invasion and predicts a poor prognosis in gastric adenocarcinoma, Am J Transl Res, 8, 2234
2016, Restoring mir122 in human stem-like hepatocarcinoma cells, prompts tumor dormancy through smad-independent TGF-β pathway, Oncotarget, 7, 71309, 10.18632/oncotarget.11885
2012, TGF beta1 and related-Smads contribute to pulmonary metastasis of hepatocellular carcinoma in mice model, J Exp Clin Cancer Res, 31, 93, 10.1186/1756-9966-31-93
2011, Comparison of adiponectin concentration between pancreatic cancer and colorectal cancer, J Gastrointest Oncol, 2, 232
2010, FOXM1 confers acquired cisplatin resistance in breast cancer cells, Mol Cancer Res, 8, 24, 10.1158/1541-7786.MCR-09-0432
2013, The Forkhead Box M1 protein regulates BRIP1 expression and DNA damage repair in epirubicin treatment, Oncogene, 32, 4634, 10.1038/onc.2012.491
2011, ATM and p53 regulate FOXM1 expression via E2F in breast cancer epirubicin treatment and resistance, Mol Cancer Ther, 10, 1046, 10.1158/1535-7163.MCT-11-0024
2016, OTUB1 inhibits the ubiquitination and degradation of FOXM1 in breast cancer and epirubicin resistance, Oncogene, 35, 1433, 10.1038/onc.2015.208
2016, Elevated expression of FoxM1 promotes the tumor cell proliferation in hepatocellular carcinoma, Tumour Biol, 37, 1289, 10.1007/s13277-015-3436-9
2013, OTUB1 modulates c-IAP1 stability to regulate signalling pathways, EMBO J, 32, 1103, 10.1038/emboj.2013.62
2013, OTU deubiquitinases reveal mechanisms of linkage specificity and enable ubiquitin chain restriction analysis, Cell, 154, 169, 10.1016/j.cell.2013.05.046